FDA plans 24 public meetings in November

The U.S. Food and Drug Administration (FDA) has scheduled 24 public meetings, conferences and workshops for November, the agency reported.

Such meetings can be on the following topics: advisory committee agendas; animal and veterinary; biologics; combination products; cosmetics; drugs; food; medical countermeasures; science and research, and tobacco products.

---

FDA Meetings, Conferences and Workshops for November

Start Date	End Date	Event	Event Type	Center
Nov. 4	Nov. 4	FDA Genetic Toxicology Workshop: How Many Doses of a DNA Reactive (Ames-positive) Drug can be Safely Administered to Healthy Subjects?	Workshop	Center for Drug Evaluation and Research
Nov. 4	Nov. 4	Use of Fecal Microbiota for Transplantation (FMT) to Treat Clostridium difficile Infection Not Responsive to Standard Therapies	Public Hearing	Center for Biologics Evaluation and Research
Nov. 4	Nov. 4	Webinar - Clinical Decision Support Software: Draft Guidance	Webcast	Center for Devices and Radiological Health
Nov. 4	Nov. 4	Health Canada and United States Food and Drug Administration Joint Regional Consultation on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use	Annual	Center for Drug Evaluation and Research
Nov. 5	Nov. 5	CDRH Industry Basics Workshop: 513(g) Requests for Information and Custom Device Exemption - November 5, 2019	Workshop	Center for Devices and Radiological Health
Nov. 6	Nov. 6	FDA-MRA Approaches to Neoadjuvant Treatment in Melanoma: A Public Workshop	Workshop	Center for Drug Evaluation and Research
Nov. 6	Nov. 7	November 6-7, 2019: General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee Meeting Announcement	Advisory Committee Meeting	Center for Devices and Radiological Health
Nov. 6	Nov. 6	Webinar - Safer Technologies Program: Draft Guidance	Webcast	Center for Devices and Radiological Health
Nov. 6	Nov. 6	The Role of Ontology and Controlled Terminology in Precision Medicine: Implications for Post-Market Surveillance	Webcast	Office of the Commissioner, Office of Regulatory Science and Innovation
Nov. 7	Nov. 7	Promoting Effective Drug Development Programs: Opportunities and Priorities for FDA’s Office of New Drugs	Workshop	Center for Drug Evaluation and Research
Nov. 7	Nov. 7	Webinar - Safety and Performance Based Pathway Performance Criteria	Webcast	Center for Devices and Radiological Health
Nov. 8	Nov. 8	Vaccines and Related Biological Products Advisory Committee November 8, 2019 Meeting Announcement	Advisory Committee Meeting	Center for Biologics Evaluation and Research
Nov. 12	Nov. 12	Advancing the Development of Pediatric Therapeutics (ADEPT 6): Pediatric Clinical Trial Endpoints for Rare Diseases With a Focus on Pediatric Patient Perspectives	Workshop	Office of the Commissioner
Nov. 13	Nov. 14	November 13-14, 2019: Immunology Devices Panel of the Medical Devices Advisory Committee Meeting Announcement	Advisory Committee Meeting	Center for Devices and Radiological Health
Nov. 13	Nov. 13	November 13, 2019: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement	Advisory Committee Meeting	Center for Drug Evaluation and Research
Nov. 14	Nov. 14	November 14, 2019: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement	Advisory Committee Meeting	Center for Drug Evaluation and Research
Nov. 14	Nov. 14	Technical and Logistical Considerations for Examining FDA-Regulated Products at International Mail Facilities using Handheld and Field-Portable Analytical Devices	Webcast	Office of the Commissioner
Nov. 14	Nov. 14	Webinar - Changes to Existing Medical Software Policies Resulting from Section 3060 of the 21st Century Cures Act: Final Guidance	Webcast	Center for Devices and Radiological Health
Nov. 18	Nov. 18	Development of Best Practices in Physiologically Based Pharmacokinetic Modeling to Support Clinical Pharmacology Regulatory Decision-Making	Meeting	Center for Drug Evaluation and Research
Nov. 18	Nov. 19	Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States	Workshop	Center for Drug Evaluation and Research
Nov. 21	Nov. 21	Office of Minority Health and Health Equity Public Meeting on Strategies to Improve Health Equity Amidst the Opioid Crisis	Meeting	Office of the Commissioner
Nov. 21	Nov. 21	Pediatric Stakeholder Meeting - A Public Meeting	Meeting	Office of the Commissioner
Nov. 21	Nov. 21	CTTI Monthly Webinar: Patient Engagement in Action: Insights from Patients & the FDA	Webcast	Center for Drug Evaluation and Research
Nov. 22	Nov. 22	Blood Products Advisory Committee November 22, 2019 Meeting Announcement	Advisory Committee Meeting	Center for Biologics Evaluation and Research

Source: U.S. Food and Drug Administration